PGF isoforms, PLGF-1 and PGF-2, in colorectal cancer and the prognostic significance

Cancer Genomics and Proteomics

Volumn 6, Issue 4, 2009, Pages 239-246

  Escudero Esparza, Astrid ^a   Martin, Tracey A ^a   Davies, Mansel Leigh ^a   Jiang, Wen G ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Colorectal cancer; Immunohistochemistry; Placenta growth factor; Prognosis; Real time quantitative polymerase chain reaction; Vascular endothelial growth factor

Indexed keywords

PLACENTAL GROWTH FACTOR; PROSTAGLANDIN F; PROSTAGLANDIN F2;

ARTICLE; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE FREE INTERVAL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTEIN EXPRESSION;

EID: 69549116791     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27-31, 1995.
2. Ferrara N and Henzel WJ: Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161: 851-858, 1989. (Pubitemid 19162712)
3. Connolly DT, Heuvelman DM, Nelson R et al: Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84: 1470-1478, 1989. (Pubitemid 19272234)
4. Ferrara N and Davis-Smyth T: The biology of vascular endothelial growth factor. Endocr Rev 18: 4-25, 1997. (Pubitemid 27076453)
5. Wirzenius M, Tammela T, Uutela M et al: Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting. J Exp Med 204: 1431-1440, 2007. (Pubitemid 46919880)
6. Marcellini M, De Luca N, Riccioni T et al: Increased melanoma growth and metastasis spreading in mice overexpressing placenta growth factor. Am J Pathol 169: 643-654, 2006. (Pubitemid 44156320)
7. Wei D, Wang L, He Y, Xiong HQ, Abbruzzese JL and Xie K: Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity. Cancer Res 64: 2030-2038, 2004. (Pubitemid 38339450)
8. Yang W, Ahn H, Hinrichs M, Torry RJ and Torry DS: Evidence of a novel isoform of placenta growth factor (PlGF-4) expressed in human trophoblast and endothelial cells. J Reprod Immunol 60: 53-60, 2003. (Pubitemid 37272295)
9. Parr C, Watkins G, Boulton M, Cai J and Jiang WG: Placenta growth factor is over-expressed and has prognostic value in human breast cancer. Eur J Cancer 41: 2819-2827, 2005. (Pubitemid 41713119)
10. Roy H, Bhardwaj S and Yla-Herttuala S: Biology of vascular endothelial growth factors. FEBS Lett 580: 2879-2887, 2006. (Pubitemid 43729175)
11. Sawano A, Takahashi T, Yamaguchi S, Aonuma M and Shibuya M: Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor. Cell Growth Differ 7: 213-221, 1996. (Pubitemid 26049830)
12. Migdal M, Huppertz B, Tessler S et al: Neuropilin-1 is a placenta growth factor-2 receptor. J Biol Chem 273: 22272-22278, 1998. (Pubitemid 28399784)
13. Zhang L, Chen J, Ke Y, Mansel RE and Jiang WG: Expression of Placenta growth factor (PlGF) in non-small cell lung cancer (NSCLC) and the clinical and prognostic significance. World J Surg Oncol 3: 68, 2005. (Pubitemid 41554617)
14. Taylor AP and Goldenberg DM: Role of placenta growth factor in malignancy and evidence that an antagonistic PlGF/Flt-1 peptide inhibits the growth and metastasis of human breast cancer xenografts. Mol Cancer Ther 6: 524-531, 2007.
15. Singh RP, Gu M and Agarwal R: Silibinin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesis. Cancer Res 65: 2043-2050, 2008.
16. Martin TA, Parr C, Davies G et al: Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist. Carcinogenesis 24: 1317-1323, 2003. (Pubitemid 37038821)
17. Martin TA, Watkins G, Mansel RE and Jiang WG: Loss of tight junction plaque molecules in breast cancer tissues is associated with a poor prognosis in patients with breast cancer. Eur J Cancer 40: 2717-2725, 2004. (Pubitemid 39574723)
18. Parr C, Gan CH, Watkins G and Jiang WG: Reduced vascular endothelial growth inhibitor (VEGI) expression is associated with poor prognosis in breast cancer patients. Angiogenesis 9: 73-81, 2006. (Pubitemid 44440552)
19. Midgley R and Kerr D: Colorectal cancer. Lancet 353: 391-399, 1999.
20. Saha S, Seghal R, Patel M et al: A multicenter trial of sentinel lymph node mapping in colorectal cancer: prognostic implications for nodal staging and recurrence. Am J Surg 191: 305-310, 2006. (Pubitemid 43265995)
21. Carmeliet P, Moons L, Luttun A et al: Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 7: 575-583, 2001. (Pubitemid 32448325)